ABSI vs VRTX: Which Stock is Better?
Side-by-side comparison of Absci Corp and Vertex Pharmaceuticals Inc in 2026
ABSI
Absci Corp
$2.90
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | ABSI | VRTX | Winner |
|---|---|---|---|
| Market Cap | $454.12M | $113.35B | VRTX |
| P/E Ratio | N/A | 31.15 | VRTX |
| EPS (TTM) | $N/A | $14.19 | VRTX |
| Revenue Growth | -0.8% | 0.1% | VRTX |
| Gross Margin | -2495.0% | 52.7% | VRTX |
Analyze ABSI
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABSI or VRTX a better investment?
Comparing ABSI and VRTX: Absci Corp has a market cap of $454.12M while Vertex Pharmaceuticals Inc has $113.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABSI and VRTX?
ABSI (Absci Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABSI or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABSI or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.8% for ABSI.
Which company is more profitable: ABSI or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 52.7% compared to -2495.0% for ABSI.
Which is the larger company: ABSI or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.35B compared to $454.12M for ABSI.
Should I buy ABSI or VRTX in 2026?
Both ABSI and VRTX have investment merit. ABSI trades at $2.90 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABSI and VRTX stock?
Key differences: Market Cap ($454.12M vs $113.35B), P/E Ratio (N/A vs 31.2x), Revenue Growth (-0.8% vs 0.1%), Gross Margin (-2495.0% vs 52.7%).